ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

Draft FY 1993 Bypass Budget Seeks $2.7 Billion, Stabilization Of Groups, Centers, And Prevention

May 10, 1991

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997